Mensinger Mike — SEC Form 4 filings
SEC reporting owner CIK 2048500. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2025-01-31 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 33,350 shares, $566,950 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 13 legs across 10 filings — 25,747 shares, $579,333 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 33,350 shares @ $17.00 ($566,950) in Beta Bionics, Inc., filed 2025-02-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | Chief Product Officer | 13 | 1 leg · 33,350 sh · $566,950 | 13 legs · 25,747 sh · $579,333 | 13 |
Form 4 filings — Mensinger Mike
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 2,650 @ $22 | EDGAR |
| 2026-09-03 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 4,375 @ $19.11 | EDGAR |
| 2026-06-03 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 4,378 @ $12.61 | EDGAR |
| 2026-03-13 | 4/A | Beta Bionics, Inc. (BBNX) | Grant/award (A): 91,520 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 109,105 @ $0 · Sale (S): 1,064 @ $12.36 · Grant/award (A): 58,749 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 2,200 @ $30.10 | EDGAR |
| 2026-01-05 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 7,200 @ $29.56 · Sale (S): 600 @ $30.20 | EDGAR |
| 2025-12-04 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 1,063 @ $29.34 | EDGAR |
| 2025-09-04 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 1,089 @ $18.86 | EDGAR |
| 2025-06-04 | 4 | Beta Bionics, Inc. (BBNX) | Sale (S): 306 @ $17.03 · Sale (S): 708 @ $18.15 · Sale (S): 101 @ $18.69 | EDGAR |
| 2025-03-03 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 35,000 @ $0 · Grant/award (A): 52,000 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Beta Bionics, Inc. (BBNX) | Conversion (C): 15,107 · Option exercise/expiry (X): 10,575 @ $0.02 · Sale (S): 13 @ $17 · Purchase (P): 33,350 @ $17 · Conversion (C): 15,107 (derivative) · Conversion (C): 10,575 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-31 | 4 | Beta Bionics, Inc. (BBNX) | Grant/award (A): 110,278 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2048500 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →